Search

Your search keyword '"Ishiki, R"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Ishiki, R" Remove constraint Author: "Ishiki, R"
37 results on '"Ishiki, R"'

Search Results

1. Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study

2. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

3. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

4. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

11. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

12. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

13. Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study.

14. [Coronary Artery Bypass Grafting for In-stent Restenosis Probably Caused by Allergic Response;Report of a Case].

15. High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

16. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes.

17. Subtle myocardial damage associated with diagnostic coronary angiography alone.

18. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.

19. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation.

20. Is it possible to predict which patients need distal protection during primary angioplasty?

21. Diversity of the elevation of serum cardiac troponin I levels in patients during their first visit to the emergency room.

22. Photocatalytic degradation of imazethapyr herbicide at TiO2/H2O interface.

23. Promising efficacy of primary gradual and prolonged balloon angioplasty in small coronary arteries: a randomized comparison with cutting balloon angioplasty and conventional balloon angioplasty.

24. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters.

25. Developmental changes of Ca(2+) handling in mouse ventricular cells from early embryo to adulthood.

26. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy.

27. Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy.

28. Different beta-adrenergic regulation of myocardial contraction and relaxation between apical and nonobstructive hypertrophic cardiomyopathy.

29. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure.

30. Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. A possible physiological marker of the transition from physiological to pathological hypertrophy.

31. A Japanese family carrying a novel mutation in the Emery-Dreifuss muscular dystrophy gene.

32. Patency of intermediate size side branches after Palmaz-Schatz stent implantation.

33. Depressed mechanoenergetics and compensatory responses in idiopathic dilated cardiomyopathy.

34. [Outcome of coronary angioplasty and coronary artery bypass grafting in patients over 75 years old].

35. Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes.

36. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.

37. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.

Catalog

Books, media, physical & digital resources